EUCAST has published an updated assessment of whole-genome sequencing for predicting bacterial antimicrobial susceptibility. We examine how far genotype can replace phenotype today and why linking both types of data is increasingly important.
EUCAST breakpoint tables version 16.1, valid from 2026-06-24. Key changes include expanded and revised breakpoints for anaerobic bacteria and a clarification on carbapenem use in carbapenemase-producing Enterobacterales.